Acute Myopia Induced by Topiramate Plus Phentermine for the Treatment of Obesity
نویسندگان
چکیده
Topiramate (TPM) iscurrently used for the treatment of epilepsy, migraine prophylaxis, bipolar diseases, and post-traumatic stress disorders. Recent studies reveal that a low-dose combination of Phentermine plus controlledrelease Topiramate (PHEN/TPM CR) as an adjunct to lifestyle modification reduces body weight in obese and overweight adults without significant side effects. We are reporting the case of an overweight young girl with acute progressive myopia due to topiramate, which was being used to treat her obesity.
منابع مشابه
A Case Report of Topiramate-induced Acute Myopia
Acute myopia following use of some drugs is a relatively rare condition. Topiramate prescribed for seizure prophylaxis is one of these drugs. In this paper a case of acute transient myopia after taking topiramate is reported. The reported patient is a 28-year old woman who had no history of any eye disease. Following consumption of topiramate pill for one week, she had found blurred vision ...
متن کاملA randomized, double-blind, placebo-controlled study of an oral, extended-release formulation of phentermine/topiramate for the treatment of obstructive sleep apnea in obese adults.
STUDY OBJECTIVES To evaluate safety and efficacy of phentermine 15 mg plus extended-release topiramate 92 mg for treatment of moderate to severe obstructive sleep apnea (OSA) in obese adults. DESIGN This phase 2, randomized, double-blind, placebo-controlled study included 2-week screening and 28-week treatment periods. Overnight polysomnography was performed at baseline, Week 8, and Week 28. ...
متن کاملA Case Report on Topiramate Induced Myopia
This is a case report of acute myopia following topiramate administration. There are several reports of this side effect recently and fortunately all of them were reversible. In our case we tried again topiramate with very low dose and increase it very slowly, the patient was followed and she tolerated it well and didnt find ocular problem anymore. So it could be suggested that starting with lo...
متن کاملManagement of obesity and cardiometabolic risk – role of phentermine/extended release topiramate
The US Food and Drug Administration (FDA) recently approved lorcaserin and the combination of phentermine and extended release topiramate (phentermine/topiramate ER) for the treatment of obesity in conjunction with a lifestyle intervention, expanding the therapeutic options for long-term obesity pharmacotherapy, which was previously limited to orlistat. Combination phentermine/topiramate ER is ...
متن کاملCardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity
Weight loss can reduce the increased cardiovascular risk associated with obesity. Pharmacotherapy is a recognized weight loss treatment option; however, cardiovascular safety issues with some previous weight loss drugs raise concerns for newly approved pharmacotherapies. Phentermine is approved for short-term obesity treatment in conjunction with lifestyle modifications, but is commonly used ch...
متن کامل